MedTrace Logo

Assessment of Annabella Breast Pump Performance

NCT04363073 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2024-03-26

No results posted yet for this study

Summary

This is an interventional, prospective, randomized, comparative, two-period cross over study to evaluate the performance of Annabella breast pump against a control breast pump.

Conditions

  • Breast Feeding

Interventions

DEVICE

Annabella Breast Pump

Milk will be expressed using Annabella breast pump for 4 consecutive days (at least 24h apart)

DEVICE

Control Breast Pump

Milk will be expressed using Control breast pump for 4 consecutive days (at least 24h apart)

Sponsors & Collaborators

  • Annabella Tech Ltd

    lead INDUSTRY

Principal Investigators

  • Revital Sheinberg, MD · Shiba Medical Center, Israel

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-30
Primary Completion
2023-04-01
Completion
2023-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04363073 on ClinicalTrials.gov